NOVARTINDBSENovartis India LtdHighNeutral
Announced Fri, 19 Jun · 19:34 IST

ChrysCapital-led Open Offer Sees Near-Zero Tendering

Listed Co AcquisitionOpen Offer TriggeredStrategic Transactions View source PDF

NOVARTIND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+6.4%1-day move
₹1392.00
prior close
₹1395.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.0+0.9+0.9+0.8+6.4+6.0+2.8+3.8+2.7+4.9+17.1+22.1
Up moveDown movePending
AI summary

Axis Capital, manager to the open offer, reports that as of June 19, 2026, only 10 equity shares (0.00 percent of offer size) had been tendered by public shareholders of Novartis India. The offer covers up to 64,19,608 shares, equal to 26 percent of voting share capital, at INR 5 face value. Acquirers are WaveRise Investments, ChrysCapital Fund X, and Two Infinity Partners, with ChrysCapital X LLC and OceanEdge Investments as persons acting in concert. NIL shares came in demat form, 10 in physical. Letter of Offer was dated June 1, 2026.

Likely market impact

Very weak response from public shareholders so far. Offer still open; acceptance depends on valid tendering and SEBI SAST checks.